Abstract
Professor Eivind Berge, MD, PhD died from cancer on 6 February 2020. He was a highly respected stroke expert, clinical trialist and clinician scientist who made substantial contributions to evidence-based stroke medicine and the work of the European Stroke Organisation.
Highlights
In his personal life, despite his tremendous work ethic and many clinical and academic commitments, he remained deeply committed to his wife and to family life
Professor Eivind Berge, MD, PhD died from cancer on 6 February 2020
That trial was published while he was working in Edinburgh, where he worked on three projects: the development of the Third International Stroke Trial (IST-3) of thrombolytic therapy for acute ischaemic stroke, a systematic review and health economic analysis of thrombolysis for stroke for the UK National Health Service Health Technology Assessment programme and on Cochrane systematic reviews of antithrombotic and thrombolytic therapy for stroke
Summary
Despite his tremendous work ethic and many clinical and academic commitments, he remained deeply committed to his wife and to family life. European Stroke Journal 2020, Vol 5(2) 113–114 ! Abstract Professor Eivind Berge, MD, PhD died from cancer on 6 February 2020.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
